Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|17 Sep 2007||Submitted||Original manuscript|
|22 Oct 2007||Reviewed||Reviewer Report - David Denhardt|
|29 Oct 2007||Reviewed||Reviewer Report - Matthias Bache|
|14 Jan 2008||Author responded||Author comments - Lucy Liaw|
|Resubmission - Version 2|
|14 Jan 2008||Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|21 Jan 2008||Reviewed||Reviewer Report - Matthias Bache|
|30 Jan 2008||Author responded||Author comments - Lucy Liaw|
|Resubmission - Version 5|
|30 Jan 2008||Submitted||Manuscript version 5|
|31 Jan 2008||Editorially accepted|
|31 Jan 2008||Article published||10.1186/1471-2407-8-38|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.